Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
N1288 IsoliquiritigeninSummary: Anti-inflammatory/antitumor reagent -
N1332 Psoralen -
N1335 5-hydroxymethyl-2-furaldehyde -
N1352 CatalpolSummary: An inhibitor of the NF-κB, EphA2/FAK/Src, and NLRP3 inflammasome signaling pathways, and an activator of the TrkB, SDF-1α/CXCR4, VEGF-PI3K/AKT, VEGF-MEK1/2/ERK1/2, and Sirt6-ERα-FasL signaling pathways. -
N1356 Asiatic acid1 CitationTarget: p38Summary: Used in wound healing;anti-inflammatory -
N1359 MagnololTarget: CB1 Receptors|NO Donors / Precursors|CB2 ReceptorsSummary: Inhibitor of NO/TNF-α production;antifungal agent -
N1360 GeniposideSummary: Iridoid glycoside with various bioactivities -
N1368 Berberine -
N1369 Bergenin -
N1370 Naringenin

